Evaluation of cefoxitin sodium therapy in anaerobic infections.
D000328:Adult; D000693:Anaerobiosis; D001424:Bacterial Infections / Q000188:drug therapy*; D002440:Cefoxitin / Q000009:adverse effects / Q000627:therapeutic use*; D002511:Cephalosporins / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008100:Liver Abscess / Q000188:drug therapy; D008169:Lung Abscess / Q000188:drug therapy; D008297:Male; D010019:Osteomyelitis / Q000188:drug therapy
D002511:Cephalosporins; D002440:Cefoxitin